Some research showed that the up-regulation of ENO1 in NSCLC [53] was associated with proliferation, migration, invasion, and tumorigenicity, although Chang et al. demonstrated that only 26% of ENO1 was expressed NSCLC, it resulted in poor clinical outcome [54]. This evidence concerns the gene ENO1 and non-small cell lung carcinoma.